Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |
mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |